Terms: = Prostate cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Treatment
16 results:
1. Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signaling.
Saxena N; Beraldi E; Fazli L; Somasekharan SP; Adomat H; Zhang F; Molokwu C; Gleave A; Nappi L; Nguyen K; Brar P; Nikesitch N; Wang Y; Collins C; Sorensen PH; Gleave M
EMBO Mol Med; 2021 May; 13(5):e13427. PubMed ID: 33709547
[TBL] [Abstract] [Full Text] [Related]
2. [Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer.].
Murray NP; Aedo S; Fuentealba C; Reyes E; Minzer S; Salazar A
Arch Esp Urol; 2019 Jun; 72(5):471-482. PubMed ID: 31223125
[TBL] [Abstract] [Full Text] [Related]
3. 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation.
Kumar D; Singh G; Sharma P; Qayum A; Mahajan G; Mintoo MJ; Singh SK; Mondhe DM; Bedi PMS; Jain SK; Gupta GK
Anticancer Agents Med Chem; 2018; 18(1):57-73. PubMed ID: 28925877
[TBL] [Abstract] [Full Text] [Related]
4. Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review.
Penning TM
Expert Opin Ther Pat; 2017 Dec; 27(12):1329-1340. PubMed ID: 28895472
[TBL] [Abstract] [Full Text] [Related]
5. Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells.
Li X; Lu J; Kan Q; Li X; Fan Q; Li Y; Huang R; Slipicevic A; Dong HP; Eide L; Wang J; Zhang H; Berge V; Goscinski MA; Kvalheim G; Nesland JM; Suo Z
Sci Rep; 2017 Jul; 7(1):5081. PubMed ID: 28698547
[TBL] [Abstract] [Full Text] [Related]
6. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized prostate cancer: Results from the prostate cancer Outcomes Study.
Hoffman RM; Koyama T; Albertsen PC; Barry MJ; Daskivich TJ; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Potosky AL; Penson DF
J Gen Intern Med; 2015 Jul; 30(7):924-34. PubMed ID: 25678374
[TBL] [Abstract] [Full Text] [Related]
7. Independent diagnostic and post-treatment prognostic models for prostate cancer demonstrate significant correlation with disease progression end points.
Graversen JA; Suh LK; Mues AC; Korets R; Donovan MJ; Khan FM; Liu Q; Landman J; Gupta M; McKiernan JM; Badani KK
J Endourol; 2012 May; 26(5):451-6. PubMed ID: 21942796
[TBL] [Abstract] [Full Text] [Related]
8. [Successful combined treatment with maximal androgen blockade (MAB), intra arterial chemotherapy and radiation for advanced prostatic ductal adenocarcinoma : report of two cases].
Nishihara C; Kuratsukuri K; Tanaka T; Kawashima H; Nakatani T
Hinyokika Kiyo; 2011 Apr; 57(4):209-12. PubMed ID: 21646853
[TBL] [Abstract] [Full Text] [Related]
9. Role of extent of fascia preservation and erectile function after robot-assisted laparoscopic prostatectomy.
van der Poel HG; de Blok W
Urology; 2009 Apr; 73(4):816-21. PubMed ID: 19195692
[TBL] [Abstract] [Full Text] [Related]
10. Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer.
Denham JW; Kumar M; Gleeson PS; Lamb DS; Joseph D; Atkinson C; Matthews J; Tai KH; Spry NA; Christie D; Turner S; Greer PB; D'Este C; Steigler A
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):404-11. PubMed ID: 19176272
[TBL] [Abstract] [Full Text] [Related]
11. Preservation of lateral prostatic fascia is associated with urine continence after robotic-assisted prostatectomy.
van der Poel HG; de Blok W; Joshi N; van Muilekom E
Eur Urol; 2009 Apr; 55(4):892-900. PubMed ID: 19171418
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
[TBL] [Abstract] [Full Text] [Related]
13. Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer.
Danjoux C; Gardner S; Fitch M
Support Care Cancer; 2007 Oct; 15(10):1169-76. PubMed ID: 17333296
[TBL] [Abstract] [Full Text] [Related]
14. Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RB; Peehl DM; Feldman D
J Nutr; 2007 Jan; 137(1 Suppl):205S-210S. PubMed ID: 17182827
[TBL] [Abstract] [Full Text] [Related]
15. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
[TBL] [Abstract] [Full Text] [Related]
16. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials.
Royston P; Sauerbrei W
Stat Med; 2004 Aug; 23(16):2509-25. PubMed ID: 15287081
[TBL] [Abstract] [Full Text] [Related]
